Print
Email
Avanir Pharmaceuticals Inc has a market cap of $319.2 million; its shares were traded at around $2.57 with and P/S ratio of 86.3.
This is the annual revenues and earnings per share of AVNR over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of AVNR.
CEO Recent Trades:
- President and CEO Keith Katkin sold 218,025 shares of AVNR stock on 11/17/2011 at the average price of 2.59. Keith Katkin owns at least 208,352 shares after this. The price of the stock has decreased by 0.77% since.
This is the insider trade history vs. stock price of AVNR. For the complete insider trading history of AVNR, click here.
Directors and Officers Recent Trades:
- Vice President, Finance Christine Ocampo sold 92,250 shares of AVNR stock on 11/11/2011 at the average price of 2.62. Christine Ocampo owns at least 52,822 shares after this. The price of the stock has decreased by 1.91% since.
- Sr. VP, Chief Medical Officer Randall Kaye sold 100,000 shares of AVNR stock on 09/09/2011 at the average price of 2.75. Randall Kaye owns at least 78,190 shares after this. The price of the stock has decreased by 6.55% since.
For the complete insider trading history of AVNR, click here.
Subscribe RSS
